Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by GAMT is a methyltransferase that converts guanidoacetate to creatine, using S-adenosylmethionine as the methyl donor. Additionally we are shipping GAMT Proteins (18) and GAMT Kits (5) and many more products for this protein.
Showing 10 out of 48 products:
Human Polyclonal GAMT Primary Antibody for IHC, WB - ABIN2775546
Borini, Staiano, Rocchia, Rossi, Rossi, DAuria: Advanced nanotechnological approaches for designing protein-based "lab-on-chips" sensors on porous silicon wafer. in Recent patents on DNA & gene sequences 2008
Show all 2 Pubmed References
Inactivation of the creatine kinase system by GAMT deficiency does not alter mitochondrial organization and intracellular compartmentation in relaxed cardiomyocytes.
GAMT was expressed highly in oligodendrocytes and olfactory ensheathing glia and moderately in astrocytes, whereas GAMT was very low in neurons and microglia.
despite the absence of Cr, GAMT-/- mice can cope with mild ischaemic stress by using phosphorylated guanidinoacetate for high energy phosphoryl transfer
GAMT(Cr)-/- mice showed differences in maximal rates of force rise and relaxation times during the isometric protocol as well as in force during the dynamic protocol.
Our results can provide the basis for additional experiments to optimize Cr supplementation in GAMT deficiency, as increases in brain Cr are slow in patients after Cr supplementation.
GAMT and AGAT (show GATM Antibodies) mRNA are up-regulated 5.4- and 1.9-fold respectively in adult mdx (show DMD Antibodies) muscle compared to C57
In the fetal brain, mRNA expression of GAMT was relatively low until 34 days gestation (term is 38-39 days). In the fetal kidney and liver, GAMT mRNA and protein expression were also relatively low until 34-37 days gestation.
Measurements of creatine and guanidinoacetate in plasma are recommended for the diagnosis of AGAT (show GATM Antibodies) and GAMT deficiency.Definitive confirmation of the diagnosis requires DNA sequencing of the appropriate gene and (if molecular analysis is ambiguous) measurement of AGAT (show GATM Antibodies) or GAMT enzyme activity or of CRTR (show SLC6A8 Antibodies)-mediated transport
Data suggest that creatine is provided equally by diet and by endogenous synthesis from arginine and glycine with successive involvement of arginine glycine amidinotransferase [AGAT (show GATM Antibodies)] and guanidinoacetate methyl transferase [GAMT]. [REVIEW]
As early diagnosis results in normal neurodevelopmental outcome, GAMT deficiency should be included in newborn screening programs to diagnose individuals at the asymptomatic stage of the disease
The estimated incidence of GAMT deficiency is 1:250,000 newborns based on our pilot study.
Study reports six novel pathogenic mutations in GAMT gene in patients with Guanidinoacetate methyltransferase deficiency.
Two novel heterozygous variants with sequence deletion and sequence insertion in the GAMT gene have been identified in newborns with guanidinoacetate methyltransferase deficiency.
impact of creatine deficiency syndrome mutations, CRTR (show SLC6A8 Antibodies) and GAMT on metabolic stress was analyzed in patient fibroblast cultures
GAMT genes may not be directly involved in human male infertility
Mutations in the GAMT gene are responsible for GAMT deficiency, since overexpression of the GAMT open reading frame restores GAMT activity in GAMT-deficient fibroblasts.
compound heterozygous mutations in the GAMT gene may be causitive in guanidinoacetate methyltransferase deficiency masquerading as a mitochondrial encephalopathy [case report]
The spatiotemporal expression pattern of gamt during zebrafish embryogenesis was revealed.
The protein encoded by this gene is a methyltransferase that converts guanidoacetate to creatine, using S-adenosylmethionine as the methyl donor. Defects in this gene have been implicated in neurologic syndromes and muscular hypotonia, probably due to creatine deficiency and accumulation of guanidinoacetate in the brain of affected individuals. Two transcript variants encoding different isoforms have been described for this gene. Pseudogenes of this gene are found on chromosomes 2 and 13.
, Guanidinoacetate N-methyltransferase
, guanidinoacetate methyltransferase